From a Shared Stress to Cell-Type-Specific Responses: The Heterogeneous Mechanisms of High Glucose-Induced Cellular

Jing Wang1, Tian Liu2, Kai Zhu3

  • 1Department of Endocrinology, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China, cdutcm.edu.cn.

Insights

Diabetic kidney disease involves cellular senescence, but high glucose affects kidney cells differently. Understanding these specific cell responses to hyperglycemia is key for new anti-senescence therapies.

Area of Science:

  • Nephrology
  • Cellular Biology
  • Diabetology

Background:

  • Diabetic kidney disease (DKD) is a major diabetes complication.
  • Cellular senescence is a critical factor in DKD pathogenesis.
  • Hyperglycemia's role in inducing senescence is complex and cell-type specific.

Purpose of the Study:

  • To systematically review the mechanisms of renal cell senescence under hyperglycemia.
  • To elucidate the heterogeneous responses of different renal cell types to high glucose.
  • To provide a foundation for targeted anti-senescence therapies for DKD.

Main Methods:

  • Systematic review of existing literature.
  • Analysis of shared and divergent pathways of cellular senescence.
  • Focus on podocytes, mesangial cells, glomerular endothelial cells, and renal tubular epithelial cells.

Main Results:

  • Hyperglycemia initiates senescence via common pathways like oxidative stress.
  • Distinct senescence programs are activated in different renal cell types.
  • Specific mechanisms include GSK3β in podocytes, STAT5/Caveolin-1 in mesangial cells, NOS/NO in endothelial cells, and mitochondrial damage in tubular cells.

Conclusions:

  • DKD pathogenesis involves diverse senescence mechanisms across renal cell types.
  • Targeting specific senescence pathways offers a novel therapeutic strategy.
  • This review provides a theoretical basis for developing new anti-senescence treatments for DKD.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75